Literature DB >> 34984594

Protective role of antithrombin III in suppressing acute responses in a rat model of renal ischemia-reperfusion injury.

Alena Firdus1, Nesina Avdagić2, Muhamed Fočak3, Maja Mitrašinović-Brulić3, Damir Suljević4.   

Abstract

Renal ischemia-reperfusion (IR) produces-induced injury and is characterized by restriction of blood supply to the kidney followed by restoration and re-oxygenation of the tissue. IR injury in the kidney contributes to pathological processes known as acute renal injury (ARI). Ischemia-perfusion injury (IRI) of the left renal artery has been demonstrated in Wistar rats. A total of 32 animals were divided into four groups: control group (SHAM), IR animals with induced ischemia-reperfusion, AT-IR animals treated by antithrombin III (AT) before IR, and AT-IR-AT animals with AT administered before and after IR. IR-induced hyperproteinemia, hyperalbuminemia, hyperglobulinemia, and a significantly low A/G ratio. Exogenous administration of AT prior to IR development effectively regulates protein fraction levels by establishing normoproteinemia. The preventive effect of AT regulates serum protein levels and reduces acute inflammation by reducing globulin and establishing physiological levels of A/G ratios. The therapeutic effect of AT given after IR is not effective compared to AT administered before IR. Protein fractions can serve as an important predictive marker for the prognosis and duration of acute inflammation. Serum globulin levels and the A/G ratio may serve as effective prognostic markers in acute inflammation caused by ischemia-reperfusion injury of the kidney. A strong correlation between globulin and the A/G ratio suggests novel markers associated with acute inflammation that can lead to chronic kidney disease.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Albumin/globulin ratio; Hyperglobulinemia; Ischemia–reperfusion injury; Total protein

Mesh:

Substances:

Year:  2022        PMID: 34984594     DOI: 10.1007/s11010-021-04322-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

Review 1.  Atherosclerotic renovascular disease.

Authors:  Sheldon W Tobe; Ellen Burgess; Marcel Lebel
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 2.  Estimation of renal function in patients with chronic kidney disease.

Authors:  Jeroen P Kooman
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

3.  Biomarkers for AKI improve clinical practice: no.

Authors:  Marlies Ostermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

4.  Biomarkers for AKI improve clinical practice: yes.

Authors:  Matthieu Legrand; Michael Darmon
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

5.  Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications.

Authors:  John R Prowle
Journal:  Intensive Care Med       Date:  2015-01-22       Impact factor: 17.440

Review 6.  Ischemic renal disease: an overlooked clinical entity?

Authors:  H R Jacobson
Journal:  Kidney Int       Date:  1988-11       Impact factor: 10.612

7.  Are serum cystatin C levels influenced by steroid doses in lupus nephritis patients?

Authors:  Marcus Vinicius Madureira e Silva; Grace Moscoso Solorzano; Sonia Kiyomi Nishida; Gianna Mastroianni Kirsztajn
Journal:  J Bras Nefrol       Date:  2011 Jul-Sep

Review 8.  New insights into the mechanisms of acute kidney injury in the intensive care unit.

Authors:  Seth D Glodowski; Gebhard Wagener
Journal:  J Clin Anesth       Date:  2014-12-03       Impact factor: 9.452

Review 9.  Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.

Authors:  S G Coca; R Yalavarthy; J Concato; C R Parikh
Journal:  Kidney Int       Date:  2007-12-19       Impact factor: 10.612

Review 10.  Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.

Authors:  Sebastian J Klein; Anna K Brandtner; Georg F Lehner; Hanno Ulmer; Sean M Bagshaw; Christian J Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2018-03-14       Impact factor: 17.440

View more
  1 in total

1.  L-cysteine protective effects against platelet disaggregation and echinocyte occurrence in gentamicin-induced kidney injury.

Authors:  Damir Suljević; Maja Mitrašinović-Brulić; Muhamed Fočak
Journal:  Mol Cell Biochem       Date:  2022-06-16       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.